Active Equities to Watch in the Healthcare Sector — Cardiovascular Systems, OraSure Technologies, Neogenomics, and BioTelemetry

NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Park Lane Advisor has initiated coverage on the following equities: Cardiovascular Systems Inc. (NASDAQ: CSII), OraSure Technologies Inc. (NASDAQ: OSUR), Neogenomics Inc. (NASDAQ: NEO), and BioTelemetry Inc. (NASDAQ: BEAT). Free research report on Cardiovascular Systems can be accessed at http://www.parklaneadvisor.com/ On Tuesday, December 15, 2015, the NASDAQ Composite ended at 4,995.36, up 0.87%, the Dow Jones Industrial Average advanced 0.90%, to finish the day at 17,524.91, and the S&P 500 closed at 2,043.41, up 1.06%. The gains were broad based as seven out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.

Cardiovascular Systems Inc.’s stock finished Tuesday’s session 3.24% higher at $14.01. A total of 1.18 million shares were traded, which was above its three months average volume of 0.58 million shares. Over the last one month and the previous three months, Cardiovascular Systems Inc.’s shares have declined 2.71% and 35.32%, respectively. Additionally, the stock has plummeted 53.42% since the beginning of 2015. The company’s shares are trading below their 50-day and 200-day moving averages by 5.31% and 46.20%, respectively. Cardiovascular Systems Inc.’s stock has a Relative Strength Index (RSI) of 42.09. Sign up and read the free notes on CSII at:

http://www.parklaneadvisor.com/

On Tuesday, shares in OraSure Technologies Inc. ended the session 4.18% higher at $6.73. The stock reported a trading volume of 1.10 million shares, above its three months average volume of 0.52 million shares. Shares of the company traded at a PE ratio of 336.50. OraSure Technologies Inc.’s shares have gained 14.65% in the last one month and 30.93% in the previous three months. However, the stock has declined 33.63% on YTD basis. The company is trading 21.86% above its 50-day moving average and 16.47% above its 200-day moving average. Moreover, shares of OraSure Technologies Inc. have an RSI of 71.59. The complimentary notes on OSUR can be downloaded in PDF format at:

http://www.parklaneadvisor.com/

Neogenomics Inc.’s stock surged 8.15%, to close the day at $7.96. The stock recorded a trading volume of 0.40 million shares, close to its three months average volume of 0.45 million shares. Neogenomics Inc.’s shares have gained 6.85% in the last one month and 18.28% in the previous three months. Furthermore, the stock has surged 90.89% since the start of this year. The company’s shares are trading 10.67% above their 50-day moving average and 33.45% above their 200-day moving average. Additionally, Neogenomics Inc. has an RSI of 58.56. Register for free on Park Lane Advisor and access the latest research on NEO at:

http://www.parklaneadvisor.com/

On Tuesday, shares in BioTelemetry Inc. recorded a trading volume of 0.15 million shares, lower than their three months average volume of 0.36 million shares. The stock ended the day 1.10% higher at $11.92. Shares of the company traded at a PE ratio of 119.20. BioTelemetry Inc.’s stock has lost 8.87% in the last one month and 22.75% in the previous three months. However, the stock has gained 18.84% on YTD basis. The company is trading above its 200-day moving average by 4.78%. Furthermore, shares of BioTelemetry Inc. have an RSI of 39.43. The complete research on BEAT is available for free at:

http://www.parklaneadvisor.com/

—

About Park Lane Advisor:

Park Lane Advisor (“PLA”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. PLA has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PLA has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). Rohit Tuli, a CFA(R) charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

PLA, the Author, the Reviewer and the Sponsor (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PLA nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.ParkLaneAdvisor.com

RESTRICTIONS

PLA is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: media (at) ParkLaneAdvisor (dot) com

SOURCE: Park Lane Advisor

ReleaseID: 434781